Another cross-species pathway has been discovered that allows interventions to lengthen life in primitive organisms, C. elegans nematode worms in this case. The pathway is related to the hypoxic response, how cells respond to protect themselves when there is insufficient oxygen. It turns out that if the hypoxic response can be turned on when normal oxygen is present, nematodes live significantly longer. A recent research report indicates that this was experimentally accomplished by breeding nematodes that could not produce the protein VHL-1which destroys another protein called HIF which keeps the hypoxic response turned off when oxygen is present. Also, it appears that the cells in such long-lived nematodes are relatively free of lipofuscin and toxic age-related protein aggregations such as seen in Alzheimer’s, Huntington’s and other age-related diseases(ref). So, as is the case for dietary restriction the increase appears to be not only in lifespan but also in healthspan. The hypoxic response pathway is different than that which is involved in calorie restriction. “VHL-1 and HIF-1 control longevity by a mechanism distinct from both dietary restriction and insulin/IGF-1-like signaling.” As of yet, however, just how HIF works downstream to extend longevity is still unclear. The hypoxic response appears to operate in higher animals as well, including humans. However, Dr. Matt Kaeberlein, University of Washington assistant professor of pathology and the senior author on the study is reported to caution that “mutation of VHL-1 is associated with a variety of tumors, and any therapies targeted toward activation of HIF would most likely need to be specific for cells that are not rapidly dividing, such as brain cells or muscle cells.” It is too early to know if a practical human anti-aging intervention can be tied to the hypoxic response but the possibility is intriguing.
Search
Calendar
Categories
- Uncategorized (412)
- Weekly Posts (2)
-
Recent Posts
- Telomerase update –arguments for and against using telomere extender supplements
- Important recent research on cancer stem cells in lung cancers
- Prostate cancer – epigenetic factors, the role of Nrf2, cancer stem cells and actions of phytochemicals
- Symposium on Cell Signaling, Inflammation and Aging
- Chronic rhinosinusitis, MRSA, biofilms and manuka honey
- New, emerging and potential treatments for cancers: Part 3 – selected less-known phytochemicals that have long been used in traditional Chinese medicine – focus on gambogic and gambogenic acids
- New, emerging and potential treatments for cancers: Part 2 – focus on anti-cancer interventions that simultaneously address multiple growth pathways
- Epigenetic Mechanisms of Long-term Memory
- New, emerging and potential treatments for cancers: Part 1 – focus on the mTOR pathway
- Focus on phytosubstances – amazing properties of epimedium and icariin
Archives
- May 2012 (1)
- April 2012 (5)
- March 2012 (4)
- February 2012 (5)
- January 2012 (5)
- December 2011 (3)
- November 2011 (4)
- October 2011 (3)
- September 2011 (4)
- August 2011 (3)
- July 2011 (4)
- June 2011 (9)
- May 2011 (9)
- April 2011 (6)
- March 2011 (7)
- February 2011 (6)
- January 2011 (7)
- December 2010 (4)
- November 2010 (9)
- October 2010 (8)
- September 2010 (7)
- August 2010 (6)
- July 2010 (7)
- June 2010 (9)
- May 2010 (7)
- April 2010 (14)
- March 2010 (13)
- February 2010 (14)
- January 2010 (15)
- December 2009 (16)
- November 2009 (14)
- October 2009 (20)
- September 2009 (16)
- August 2009 (19)
- July 2009 (22)
- June 2009 (24)
- May 2009 (22)
- April 2009 (18)
- March 2009 (20)
- February 2009 (19)
- January 2009 (6)
Meta